Opana(®) ER induced thrombotic thrombocytopenic purpura

We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotbi, Nabil, Han, Bernadine, Cheng, Duncan, Odom, Anna E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425330/
https://www.ncbi.nlm.nih.gov/pubmed/25995651
http://dx.doi.org/10.2147/IMCRJ.S65655
Descripción
Sumario:We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.

Ejemplares similares